Dignify Therapeutics is a neurological drug and medical device development company focused on delivering novel therapies for neurogenic bladder and bowel disorders in spinal cord injured, multiple sclerosis and similar patient populations.
External link for Dignify Therapeutics
P.O. Box 13169
2 Davis Drive
Research Triangle Park, NC 27709, US
Dignify Therapeutics reposted this
This is what keeps Dignify Therapeutics motivated...helping people who continuously work to overcome physical, financial, professional, social, and government support challenges despite neurological injury or disease. https://lnkd.in/enD9TGig
Dignify Therapeutics reposted this
[SCI Accelerate Program 2024]: We are proud to introduce Dignify Therapeutics that has been selected to participate in the SCI Accelerate Program 2024. Karl Thor Anthony DiTonno Ed Burgard Dignify Therapeutics has two drug platforms at the IND-enabling stage for on-demand defecation and micturition and an implantable neuromodulation platform at the IDE-enabling stage. They have just received 2 NIH awards for controlling urinary and fecal incontinence as well as autonomic dysreflexia that occurs with bowel and bladder manipulations. About Praxis SCI Accelerate Program: The SCI Accelerate Program provides support and resources to help startups grow and address care and cure-related treatments that improve quality of life for people with spinal cord injury (SCI). Read more here: https://lnkd.in/gTT9kS-X Learn more about our cohort here: https://lnkd.in/grDuWxrX Stay tuned for more updates on the Accelerate Program and the amazing progress of our cohort startups. #SCIAccelerate #startups #innovation Shweta Shekhar Arushi Raina Tathagata Ray, PhD, MBA Andrew Forshner Spring Hawes, BC MGC Barry Munro John Chernesky Richard Peter James Jay Laskin
Dignify will be presenting an update on a new treatment for neurogenic bladder/bowel dysfunction at the Therapeutics Development at NINDS event! Join Dignify President Dr. Ed Burgard at the Society for Neuroscience meeting in Chicago on Monday, Oct 7 at 6:30pm for exciting developments. https://lnkd.in/e9hXBfe4
Dignify Therapeutics reposted this
Eva Garland Consulting, LLC is excited to congratulate one of our first and longest standing clients, Dignify Therapeutics, on receiving two new The National Institutes of Health grants! Dignify is dedicated to tackling unmet medical needs that larger pharmaceutical companies often overlook, particularly for individuals with bladder and bowel disorders stemming from spinal injuries and other conditions. The new grant awards will significantly boost Dignify's research and development initiatives. For over a decade, EGC has proudly supported Dignify through grant writing assistance and ongoing accounting and compliance services. Over the years, Dignify has successfully secured over $20 million in non-dilutive grant funding. As Dr. Ed Burgard, a key member of the Dignify team, notes, “It was through EGC's guidance that we were able to develop our non-dilutive funding approach, which started 10 years of consistent funding.” We’re excited to witness Dignify’s continued growth and their impactful contributions to therapeutic solutions. We're incredibly grateful they agreed to be featured in our October Newsletter! Check it out here: https://lnkd.in/en3iY3aj #Innovation #SBIR #NIH #Entrepreneurship #BioTech
September is Spinal Cord Injury Awareness Month! Join Dignify Therapeutics in developing new treatments for individuals with SCI. #SpinalCordInjuryAwarenessMonth